Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Simple sequence repeat polymorphism within the p53 gene

V Lazar1, F Hazard, F Bertin

  • 1Laboratoire d'Immunologie Moléculaire, Institut Gustave Roussy, Villejuif, France.

Oncogene
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sortilin exhibits tumor suppressor-like activity by limiting EGFR transduction function.

Oncogene·2026
Same author

Bridge percolation: electrical connectivity of discontinued conducting slabs by metallic nanowires.

Nanoscale·2024
Same author

The Frequency of Germline BRCA and Non-BRCA HR-Gene-Variants in a Cohort of Pancreatic Cancer Patients.

Digestive diseases and sciences·2022
Same author

[Medulloblastoma : management of a usually pediatric tumour in a young adult].

Revue medicale de Liege·2022
Same author

Assessment of neuropsychological impairments in regular cannabis users.

L'Encephale·2021
Same author

[Multiple myeloma in an elderly patient with history of breast cancer : the value of multidisciplinary oncogeriatric collaboration].

Revue medicale de Liege·2021
Same journal

SRD5A3-mediated aberrant N-glycosylation of SCARA5 promotes ferroptosis in lung adenocarcinoma.

Oncogene·2026
Same journal

Aberrant splicing in human cancer shows possible functional impact on transcription factors.

Oncogene·2026
Same journal

The crosstalk between RNA m6A modification and protein lactylation: emerging insights into tumor progression.

Oncogene·2026
Same journal

Correction: Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.

Oncogene·2026
Same journal

Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C-mutant non-small cell lung cancer.

Oncogene·2026
Same journal

Histone lactylation-driven IGF2BP3 promotes intrahepatic cholangiocarcinoma progression via SPP1/CD44-dependent macrophage polarization.

Oncogene·2026
See all related articles

A novel p53 gene polymorphism in intron 3 was identified. This genetic variation was found in 28% of Caucasians, and p53 allelic losses were observed in breast tumors from heterozygote patients.

Area of Science:

  • Genetics
  • Molecular Biology
  • Oncology

Background:

  • The p53 gene is a critical tumor suppressor.
  • Genetic variations can influence cancer susceptibility and progression.
  • Intronic polymorphisms may affect gene function or expression.

Purpose of the Study:

  • To identify and characterize novel polymorphisms in the p53 gene.
  • To investigate the frequency of a newly discovered p53 polymorphism in a Caucasian population.
  • To explore the association between this p53 polymorphism and p53 allelic loss in breast tumors.

Main Methods:

  • DNA sequencing to identify novel polymorphisms.
  • Polymerase Chain Reaction (PCR)-based analysis for genotyping.
  • Analysis of p53 allelic status in tumor samples from patients with the polymorphism.

Related Experiment Videos

Main Results:

  • A new 16-nucleotide repeat polymorphism was identified in intron 3 of the p53 gene.
  • This polymorphism was present in 28% of the 82 Caucasian individuals tested (heterozygotes).
  • p53 allelic losses were detected in 50% (3 out of 6) of breast tumors from heterozygote patients.

Conclusions:

  • A novel p53 gene polymorphism in intron 3 has been described.
  • The polymorphism is relatively common in the Caucasian population.
  • The findings suggest a potential link between this p53 polymorphism and p53 allelic loss in breast cancer.